Humana Reaffirms FY 2026 EPS Guidance in 8-K Filing
Humana Inc.
Subscribe to track HUM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Humana Inc. (HUM) has filed an 8-K reaffirming its full-year 2026 guidance. Management projects GAAP diluted EPS of at least $8.89 and Adjusted EPS of at least $9.00. This disclosure coincides with upcoming investor meetings scheduled through March 31, 2026.
Comprehensive Analysis
Regulation FD Disclosure
Humana Inc. (HUM) filed a Form 8-K on March 2, 2026, to disclose information shared during upcoming meetings with investors and analysts scheduled between March 2 and March 31, 2026.
Guidance Reaffirmation: The company reaffirmed its financial guidance for the fiscal year ending December 31, 2026 (FY 2026).
- GAAP Diluted EPS: Expected to be at least $8.89.
- Adjusted EPS: Expected to be at least $9.00.
Reconciliation Details: The difference between the GAAP and Adjusted figures is primarily attributed to the amortization of identifiable intangibles ($0.15 per share) and a cumulative net tax impact ($-0.04 per share). This guidance remains consistent with the figures previously issued in the company's press release on February 11, 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.